Juan Andrés De Pablo Moreno and Colleagues on Therapeutic FVIII Administration in Hemarthrosis in Mice
Journal of Thrombosis and Haemostasis (JTH) shared on LinkedIn:
”Defective lymphangiogenesis and iron removal after hemarthrosis in factor VIII–deficient mice are rectified with therapeutic factor VIII administration — implications for joint health
By Bilgimol Chumappumkal Joseph, Juan Andrés De Pablo Moreno, Nicca Falah, Mia Lora Cacho, and Annette von Drygalski
Recurrent joint bleeding in hemophilia leads to iron deposition, impaired lymphangiogenesis, and progressive arthropathy.
In a murine model of factor VIII deficiency, researchers compared saline, short-course recombinant FVIII, and prolonged murine Fc-FVIII therapy following induced knee hemarthrosis.
Sustained FVIII activity (~30–40%) enabled normal lymphangiogenesis, rapid iron clearance, and cartilage recovery, whereas short or absent replacement resulted in synovial iron overload and poor repair.”
Read the full article in JTH.
Article: Defective lymphangiogenesis and iron removal after hemarthrosis in factor VIII-deficient mice are rectified with therapeutic factor VIII administration—implications for joint health
Authors: Bilgimol Chumappumkal Joseph, Juan Andrés De Pablo Moreno, Nicca Falah, Mia Lora Cacho, Annette von Drygalski

Stay updated on all scientific advances with Hemostasis Today.
-
May 27, 2026, 04:47Daniel Torrent: The Overlooked Epidemic of Post-Thrombotic Syndrome
-
May 27, 2026, 04:45Graziella Pompei: Is Aspirin Still a Valid Alternative to Clopidogrel in PCI with DES Implantation?
-
May 27, 2026, 04:40Kausik Ray: Phase 1 Trial Highlights Anti-Inflammatory Effects of Ruvonoflast
-
May 27, 2026, 04:29Francisco Chacón-Lozsán: High-Sensitivity Troponin and the Evolving Management of NSTEMI
-
May 27, 2026, 04:14Michael R. Jaff: HI-PEITHO Trial and NEWS Score Insights on Advances for Intermediate-Risk Pulmonary Embolism
-
May 26, 2026, 16:45Ashley George: Take the Leap for Thrombosis UK
-
May 26, 2026, 16:40Hamed Helisaz: Machine Learning for Detecting Missing Heart Medications
-
May 26, 2026, 15:32Haroun Gajraj: Brown Marks After Microsclerotherapy – What Every Practitioner Needs to Know
-
May 26, 2026, 15:29Jacqueline van Paassen: Lack of Essential Clinical Data in DOAC Prescriptions in Community Pharmacies